These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 19953275
1. Mycophenolate mofetil therapy for children with steroid-resistant nephrotic syndrome. Li Z, Duan C, He J, Wu T, Xun M, Zhang Y, Yin Y. Pediatr Nephrol; 2010 May; 25(5):883-8. PubMed ID: 19953275 [Abstract] [Full Text] [Related]
2. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children. Kang Z, Li Z, Duan C, Wu T, Xun M, Ding Y, Zhang Y, Zhang L, Yin Y. Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534 [Abstract] [Full Text] [Related]
3. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report]. Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA. Przegl Lek; 2006 Jul; 63 Suppl 3():44-8. PubMed ID: 16898486 [Abstract] [Full Text] [Related]
4. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome. Mendizábal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simon J. Pediatr Nephrol; 2005 Jul; 20(7):914-9. PubMed ID: 15891923 [Abstract] [Full Text] [Related]
5. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study. Li X, Tian J, Wu J, He Q, Li H, Han F, Li Q, Chen Y, Ni Q, Chen J. Clin Ther; 2009 Apr; 31(4):741-50. PubMed ID: 19446147 [Abstract] [Full Text] [Related]
6. [A prospective multicenter clinical control trial on treatment of refractory nephrotic syndrome with mycophenolate mofetil in children]. Yi ZW, Wu XC, Xu H, Zhou LJ, Wu YB, Feng SP, Zhou JH, Yang Q, Zhu GH, Liu AM, Wei MJ, Yu L, Zeng ZF. Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):575-8. PubMed ID: 18947472 [Abstract] [Full Text] [Related]
7. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome. Sinha A, Gupta A, Kalaivani M, Hari P, Dinda AK, Bagga A. Kidney Int; 2017 Jul; 92(1):248-257. PubMed ID: 28318625 [Abstract] [Full Text] [Related]
8. Interventions for idiopathic steroid-resistant nephrotic syndrome in children. Liu ID, Willis NS, Craig JC, Hodson EM. Cochrane Database Syst Rev; 2019 Nov 21; 2019(11):. PubMed ID: 31749142 [Abstract] [Full Text] [Related]
9. Interventions for idiopathic steroid-resistant nephrotic syndrome in children. Hodson EM, Wong SC, Willis NS, Craig JC. Cochrane Database Syst Rev; 2016 Oct 11; 10(10):CD003594. PubMed ID: 27726125 [Abstract] [Full Text] [Related]
10. Mycophenolate mofetil in treatment of childhood steroid-resistant nephrotic syndrome. Gargah TT, Lakhoua MR. J Nephrol; 2011 Oct 11; 24(2):203-7. PubMed ID: 21319130 [Abstract] [Full Text] [Related]
11. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome. Bagga A, Hari P, Moudgil A, Jordan SC. Am J Kidney Dis; 2003 Dec 11; 42(6):1114-20. PubMed ID: 14655181 [Abstract] [Full Text] [Related]
12. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome. Gellermann J, Ehrich JH, Querfeld U. Nephrol Dial Transplant; 2012 May 11; 27(5):1970-8. PubMed ID: 21976740 [Abstract] [Full Text] [Related]
13. Mycophenolate mofetil therapy for children with intractable nephrotic syndrome. Okada M, Sugimoto K, Yagi K, Yanagida H, Tabata N, Takemura T. Pediatr Int; 2007 Dec 11; 49(6):933-7. PubMed ID: 18045300 [Abstract] [Full Text] [Related]
14. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome. Wang J, Mao J, Chen J, Fu H, Shen H, Zhu X, Liu A, Shu Q, Du L. Nephrology (Carlton); 2016 Jan 11; 21(1):21-7. PubMed ID: 26697959 [Abstract] [Full Text] [Related]
15. Mycophenolate mofetil for treatment of idiopathic nephrotic syndrome in children. Nickavar A, Safarzadeh AE, Sotoudeh K, Otukesh H, Hooman N. Iran J Kidney Dis; 2012 Sep 11; 6(5):346-9. PubMed ID: 22976259 [Abstract] [Full Text] [Related]
16. Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome. Dehoux L, Hogan J, Dossier C, Fila M, Niel O, Maisin A, Macher MA, Kwon T, Baudouin V, Deschênes G. Pediatr Nephrol; 2016 Nov 11; 31(11):2095-101. PubMed ID: 27263020 [Abstract] [Full Text] [Related]
17. [Mycophenolate mofetil in the treatment of primary nephrotic syndrome]. Zhao M, Chen X, Chen Y, Liu Z, Liu Y, Lu F, Zhang Y, Wang H. Zhonghua Yi Xue Za Zhi; 2001 May 10; 81(9):528-31. PubMed ID: 11809115 [Abstract] [Full Text] [Related]
18. Clinical observations of mycophenolate mofetil therapy in refractory primary nephrotic syndrome. Zhao M, Chen X, Chen Y, Liu Z, Liu Y, Lu F, Zhang Y, Wang H. Nephrology (Carlton); 2003 Jun 10; 8(3):105-9. PubMed ID: 15012724 [Abstract] [Full Text] [Related]
19. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing. Wu B, Mao J, Shen H, Fu H, Wang J, Liu A, Gu W, Shu Q, Du L. Nephrology (Carlton); 2015 Jan 10; 20(1):18-24. PubMed ID: 25312783 [Abstract] [Full Text] [Related]
20. Switch from cyclosporine A to mycophenolate mofetil in nephrotic children. Ulinski T, Dubourg L, Saïd MH, Parchoux B, Ranchin B, Cochat P. Pediatr Nephrol; 2005 Apr 10; 20(4):482-5. PubMed ID: 15719253 [Abstract] [Full Text] [Related] Page: [Next] [New Search]